Abstract:With the growing prevalence of diabetes, there is an urgent demand for a user‐friendly treatment option that minimizes side effects related to the use of subcutaneous injections. Scientists have dedicated over a century to developing an oral dosage form of insulin that can be administrated orally. The oral route of administration is the most desirable route for regularly dosed drugs in terms of safety and patient compliance. However, oral delivery of insulin remains a formidable challenge due to its intrinsically limited ability to cross the intestinal epithelium membrane and susceptibility to enzymatic degradation. This article reviews oral insulin research over the past decade, with a particular focus on surface modifications of nanoparticles (NPs). Various strategies involving controlling surface charges, utilizing protective proteins, and targeting specific receptors with ligands have been explored. Notably, surface modifications of the NPs for targeting specific intestinal receptors have shown promise in enhancing insulin oral absorption and bioavailability. Advanced technologies such as oral microneedles and gene therapy have also been developed, but their safety requires further assessment. Despite encouraging preclinical results across numerous strategies, the current clinical evidence is less optimistic. In summary, the present findings highlight the substantial journey that still lies ahead before achieving successful oral delivery of insulin. Practical Applications: This review provides a summary of recent progress in oral insulin delivery, particularly highlighting surface‐modified functional nanoparticles serving as an effective drug delivery system, which offers valuable information to the researchers. Due to the limited effectiveness of oral protein drugs caused by biological barriers, innovative technologies and drug delivery systems have been developed to overcome these obstacles and achieve therapeutic goals. This review concluded that surface modifications to nanoparticles can improve insulin stability and permeability, thereby enhancing oral bioavailability. It could assist researchers in developing more effective and patient‐friendly oral drug delivery systems.

Advancements in Oral Drug Delivery of Insulin: A Review

Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus

Oral Insulin Delivery: A Review On Recent Advancements And Novel Strategies.

A comprehensive review of oral chitosan drug delivery systems: Applications for oral insulin delivery

Recent advances in oral insulin delivery technologies

Various non-injectable delivery systems for the treatment of diabetes mellitus

Advancements in Oral Insulin: A Century of Research and the Emergence of Targeted Nanoparticle Strategies

Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures

Materials and structure of polysaccharide-based delivery carriers for oral insulin: A review

Current challenges in non-invasive insulin delivery systems: A comparative review

Challenges and recent advances in the subcutaneous delivery of insulin.

A review of biodegradable polymeric systems for oral insulin delivery

Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery

Recent Advances and Perspectives in Novel Insulin Release Systems

Material design for oral insulin delivery

Recent advances in transdermal insulin delivery technology: A review

Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.

Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes

Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges

Oral Delivery of Insulin by Barbed Microneedles Actuated by Intestinal Peristalsis

Review of Point-of-care Platforms for Diabetes: (2) Medications and Devices